Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tetsuro Matano

Showing results (81-90 of 162) with videos related to

Pageof 17
Sort By:
The Journal of General Virology|January 26, 2007
Vaccine-based, long-term, stable control of simian/human immunodeficiency virus 89.6PD replication in rhesus macaquesHiroyuki Yamamoto, Miki Kawada, Tetsuo Tsukamoto, et al.
Vaccine|September 25, 2008
Potent specific immune responses induced by prime-boost-boost strategies based on DNA, adenovirus, and Sendai virus vectors expressing gag gene of Chinese HIV-1 subtype BShuangqing Yu, Xia Feng, Tsugumine Shu, et al.
Preventive Medicine Reports|November 14, 2019
Estimating HIV-1 incidence in Japan from the proportion of recent infectionsSaori Matsuoka, Mami Nagashima, Kenji Sadamasu, et al.
Microbiology Spectrum|July 10, 2023
Breadth and Durability of SARS-CoV-2-Specific T Cell Responses following Long-Term Recovery from COVID-19Thi Thu Thao Dang, Alitzel Anzurez, Kaori Nakayama-Hosoya, et al.
Journal of Virology|October 25, 2013
Control of simian immunodeficiency virus replication by vaccine-induced Gag- and Vif-specific CD8+ T cellsNami Iwamoto, Naofumi Takahashi, Sayuri Seki, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 1, 2022
Env-independent protection of intrarectal SIV challenge by vaccine induction of Gag/Vif-specific CD8<sup>+</sup> T cells but not CD4<sup>+</sup> T cellsHiroshi Ishii, Kazutaka Terahara, Takushi Nomura, et al.
Vaccine|September 24, 2011
Intranasal Sendai viral vector vaccination is more immunogenic than intramuscular under pre-existing anti-vector antibodiesChikaya Moriya, Satoshi Horiba, Kyoko Kurihara, et al.
Journal of Virology|February 2, 2022
Sustainable Antiviral Efficacy of Rejuvenated HIV-Specific Cytotoxic T Lymphocytes Generated from Induced Pluripotent Stem CellsShoji Miki, Yohei Kawai, Kaori Nakayama-Hosoya, et al.
Immunogenetics|July 20, 2010
Diversity of MHC class I genes in Burmese-origin rhesus macaquesTaeko K Naruse, Zhiyong Chen, Risa Yanagida, et al.
Frontiers in Immunology|June 12, 2026
Correction: Non-human primate preclinical model revealed the feasibility and short-term safety of iPSC-derived innate-like T cells in autologous transplantationYasuyuki Miyake, Shoichi Iriguchi, Ai Kawana-Tachikawa, et al.
Pageof 17

Showing results (81-90 of 162) with videos related to

Sort By:
Pageof 17
The Journal of General Virology|January 26, 2007
Vaccine-based, long-term, stable control of simian/human immunodeficiency virus 89.6PD replication in rhesus macaquesHiroyuki Yamamoto, Miki Kawada, Tetsuo Tsukamoto, et al.
Vaccine|September 25, 2008
Potent specific immune responses induced by prime-boost-boost strategies based on DNA, adenovirus, and Sendai virus vectors expressing gag gene of Chinese HIV-1 subtype BShuangqing Yu, Xia Feng, Tsugumine Shu, et al.
Preventive Medicine Reports|November 14, 2019
Estimating HIV-1 incidence in Japan from the proportion of recent infectionsSaori Matsuoka, Mami Nagashima, Kenji Sadamasu, et al.
Microbiology Spectrum|July 10, 2023
Breadth and Durability of SARS-CoV-2-Specific T Cell Responses following Long-Term Recovery from COVID-19Thi Thu Thao Dang, Alitzel Anzurez, Kaori Nakayama-Hosoya, et al.
Journal of Virology|October 25, 2013
Control of simian immunodeficiency virus replication by vaccine-induced Gag- and Vif-specific CD8+ T cellsNami Iwamoto, Naofumi Takahashi, Sayuri Seki, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 1, 2022
Env-independent protection of intrarectal SIV challenge by vaccine induction of Gag/Vif-specific CD8<sup>+</sup> T cells but not CD4<sup>+</sup> T cellsHiroshi Ishii, Kazutaka Terahara, Takushi Nomura, et al.
Vaccine|September 24, 2011
Intranasal Sendai viral vector vaccination is more immunogenic than intramuscular under pre-existing anti-vector antibodiesChikaya Moriya, Satoshi Horiba, Kyoko Kurihara, et al.
Journal of Virology|February 2, 2022
Sustainable Antiviral Efficacy of Rejuvenated HIV-Specific Cytotoxic T Lymphocytes Generated from Induced Pluripotent Stem CellsShoji Miki, Yohei Kawai, Kaori Nakayama-Hosoya, et al.
Immunogenetics|July 20, 2010
Diversity of MHC class I genes in Burmese-origin rhesus macaquesTaeko K Naruse, Zhiyong Chen, Risa Yanagida, et al.
Frontiers in Immunology|June 12, 2026
Correction: Non-human primate preclinical model revealed the feasibility and short-term safety of iPSC-derived innate-like T cells in autologous transplantationYasuyuki Miyake, Shoichi Iriguchi, Ai Kawana-Tachikawa, et al.
Pageof 17